Skip to main content

Table 4 Mean baseline and post-dose shifts in FEV1 for each treatment arm

From: The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study

Treatment: Baseline FEV1 (L) FEV1 1 h (L) FEV1 24 h (L) FEV1 48 h (L)
LAMA 3.25
[2.77-3.73]
3.31
[2.86-3.76]
3.33
[2.87-3.79]
3.26
[2.82-3.71]
uLABA 3.32
[2.91-3.72]
3.31
[2.91-3.72]
3.34
[2.94-3.73]
3.29
[2.89-3.69]
Combo 3.16
[2.70-3.62]
3.25
[2.77-3.72]
3.26
[2.78-3.74]
3.32
[2.83-3.81]
  1. [], 95% confidence intervals; FEV 1 , forced expiratory volume in 1 s, LAMA long-acting muscarinic antagonist, uLABA ultra-long acting β2 agonist, Combo combination therapy